$DZSI
DZS INC.

2013 Q2 Form 10-Q Financial Statement

#000144530513002085 Filed on August 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $30.05M $30.84M
YoY Change -2.55% -1.47%
Cost Of Revenue $18.44M $21.56M
YoY Change -14.5% 6.6%
Gross Profit $11.61M $9.272M
YoY Change 25.24% -16.21%
Gross Profit Margin 38.64% 30.07%
Selling, General & Admin $6.598M $6.544M
YoY Change 0.83% -12.65%
% of Gross Profit 56.82% 70.58%
Research & Development $3.920M $4.820M
YoY Change -18.67% -11.54%
% of Gross Profit 33.76% 51.98%
Depreciation & Amortization $90.00K $80.00K
YoY Change 12.5% -82.22%
% of Gross Profit 0.78% 0.86%
Operating Expenses $10.52M $11.36M
YoY Change -7.44% -12.19%
Operating Profit $1.094M -$2.092M
YoY Change -152.29% 11.57%
Interest Expense $10.00K $9.000K
YoY Change 11.11% -67.86%
% of Operating Profit 0.91%
Other Income/Expense, Net $12.00K $15.00K
YoY Change -20.0% 7.14%
Pretax Income $1.096M -$2.086M
YoY Change -152.54% 10.43%
Income Tax $40.00K $16.00K
% Of Pretax Income 3.65%
Net Earnings $1.056M -$2.102M
YoY Change -150.24% 10.86%
Net Earnings / Revenue 3.51% -6.82%
Basic Earnings Per Share $0.03 -$0.07
Diluted Earnings Per Share $0.03 -$0.07
COMMON SHARES
Basic Shares Outstanding 31.22M shares 30.99M shares
Diluted Shares Outstanding 32.70M shares 30.99M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.70M $13.10M
YoY Change -3.05% -32.12%
Cash & Equivalents $12.72M $13.13M
Short-Term Investments
Other Short-Term Assets $1.900M $2.400M
YoY Change -20.83% -11.11%
Inventory $20.14M $27.66M
Prepaid Expenses
Receivables $27.77M $25.46M
Other Receivables $0.00 $0.00
Total Short-Term Assets $62.58M $68.64M
YoY Change -8.82% -10.28%
LONG-TERM ASSETS
Property, Plant & Equipment $623.0K $584.0K
YoY Change 6.68% -88.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $185.0K $214.0K
YoY Change -13.55% 7.0%
Total Long-Term Assets $808.0K $798.0K
YoY Change 1.25% -85.22%
TOTAL ASSETS
Total Short-Term Assets $62.58M $68.64M
Total Long-Term Assets $808.0K $798.0K
Total Assets $63.39M $69.44M
YoY Change -8.7% -15.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.904M $12.04M
YoY Change -34.34% 20.37%
Accrued Expenses $9.000M $8.800M
YoY Change 2.27% -25.42%
Deferred Revenue
YoY Change
Short-Term Debt $10.00M $10.00M
YoY Change 0.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.92M $30.81M
YoY Change -12.61% -3.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.011M $4.085M
YoY Change -26.29% -7.16%
Total Long-Term Liabilities $3.011M $4.085M
YoY Change -26.29% -7.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.92M $30.81M
Total Long-Term Liabilities $3.011M $4.085M
Total Liabilities $29.93M $34.89M
YoY Change -14.21% -3.87%
SHAREHOLDERS EQUITY
Retained Earnings -$1.040B -$1.038B
YoY Change 0.21%
Common Stock $1.073B $1.072B
YoY Change 0.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $33.46M $34.54M
YoY Change
Total Liabilities & Shareholders Equity $63.39M $69.44M
YoY Change -8.7% -15.22%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $1.056M -$2.102M
YoY Change -150.24% 10.86%
Depreciation, Depletion And Amortization $90.00K $80.00K
YoY Change 12.5% -82.22%
Cash From Operating Activities $1.240M -$1.890M
YoY Change -165.61% -377.94%
INVESTING ACTIVITIES
Capital Expenditures -$90.00K -$100.0K
YoY Change -10.0% -81.13%
Acquisitions
YoY Change
Other Investing Activities $60.00K
YoY Change
Cash From Investing Activities -$90.00K -$50.00K
YoY Change 80.0% -90.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 50.00K
YoY Change -100.0% 150.0%
NET CHANGE
Cash From Operating Activities 1.240M -1.890M
Cash From Investing Activities -90.00K -50.00K
Cash From Financing Activities 0.000 50.00K
Net Change In Cash 1.150M -1.890M
YoY Change -160.85% -1211.76%
FREE CASH FLOW
Cash From Operating Activities $1.240M -$1.890M
Capital Expenditures -$90.00K -$100.0K
Free Cash Flow $1.330M -$1.790M
YoY Change -174.3% -247.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7229000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7904000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27774000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25820000 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14842000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14668000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
216000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
133000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1072839000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1073154000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2122000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3018000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3018000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5827000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5827000 shares
CY2013Q2 us-gaap Assets
Assets
63392000 USD
CY2012Q4 us-gaap Assets
Assets
61724000 USD
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31116000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
31000 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
31000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5532000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1203000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
978000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
60933000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
62584000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11119000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12722000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18190000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13130000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5060000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1603000 USD
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31116000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31325000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31325000 shares
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
18436000 USD
us-gaap Cost Of Revenue
CostOfRevenue
36311000 USD
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
21563000 USD
us-gaap Cost Of Revenue
CostOfRevenue
40245000 USD
CY2013Q2 us-gaap Debt Instrument Basis Spread On Variable Rate
DebtInstrumentBasisSpreadOnVariableRate
0.035
us-gaap Depreciation And Amortization
DepreciationAndAmortization
174000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
157000 USD
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.04
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.03
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-16000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-83000 USD
CY2013Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
248000 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
248000 USD
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1719000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3214000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1525000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3813000 USD
us-gaap Gross Profit
GrossProfit
22116000 USD
us-gaap Gross Profit
GrossProfit
17652000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
9272000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
11612000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
61000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2086000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5467000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1358000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1096000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
675000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
240000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5352000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2766000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-525000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1551000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
265000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1261000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-23000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-279000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-645000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-58000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1474000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
689000 shares
us-gaap Interest Expense
InterestExpense
49000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
10000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
9000 USD
us-gaap Interest Expense
InterestExpense
27000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26923000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26065000 USD
CY2013Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
10000000 USD
CY2012Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2014-03-12
CY2013Q2 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0377
CY2012Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000.0 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9178000 USD
CY2013Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9373000 USD
CY2013Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
4600000 USD
us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025
CY2012Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10000000 USD
CY2013Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10000000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6127000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5682000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
21404000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
20143000 USD
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12108000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13226000 USD
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2353000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2051000 USD
CY2013Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2067000 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2067000 USD
CY2013Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
10400000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
29784000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
29934000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61724000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63392000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4885000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-136000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-214000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1897000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
1056000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-2102000 USD
us-gaap Net Income Loss
NetIncomeLoss
1286000 USD
us-gaap Net Income Loss
NetIncomeLoss
-5516000 USD
us-gaap Operating Expenses
OperatingExpenses
20689000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
10518000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
11364000 USD
us-gaap Operating Expenses
OperatingExpenses
23098000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2092000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1094000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5446000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1427000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4130000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
40000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
407000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1263000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1572000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
848000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
208000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
185000 USD
CY2013Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-78000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-83000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-16000 USD
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-20000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3719000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3011000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
214000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2590000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1945000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
115000 USD
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1546000 USD
CY2012Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1575000 USD
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1480000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1499000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
575000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
455000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
436000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
604000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15251000 USD
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15465000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
583000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
623000 USD
CY2013Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
3777000 USD
CY2012Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
3758000 USD
CY2013Q1 us-gaap Quantifying Misstatement In Current Year Financial Statements Amount
QuantifyingMisstatementInCurrentYearFinancialStatementsAmount
600000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
5000000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4820000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7580000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3920000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9745000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1041146000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1039860000 USD
us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:6px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue when the earnings process is complete. The Company recognizes product revenue upon shipment of product under contractual terms which transfer title to customers upon shipment, under normal credit terms, net of estimated sales returns and allowances at the time of shipment. Revenue is deferred if there are significant post-delivery obligations or if the fees are not fixed or determinable. When significant post-delivery obligations exist, revenue is deferred until such obligations are fulfilled. The Company&#8217;s arrangements generally do not have any significant post-delivery obligations. If the Company&#8217;s arrangements include customer acceptance provisions, revenue is recognized upon obtaining the signed acceptance certificate from the customer, unless the Company can objectively demonstrate that the delivered products or services meet all the acceptance criteria specified in the arrangement prior to obtaining the signed acceptance.&#160;In those instances where revenue is recognized prior to obtaining the signed acceptance certificate, the Company uses successful completion of customer testing as the basis to objectively demonstrate that the delivered products or services meet all the acceptance criteria specified in the arrangement. The Company also considers historical acceptance experience with the customer, as well as the payment terms specified in the arrangement, when revenue is recognized prior to obtaining the signed acceptance certificate. When collectability is not reasonably assured, revenue is recognized when cash is collected.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company makes certain sales to product distributors. These customers are given certain privileges to return a portion of inventory. Return privileges generally allow distributors to return inventory based on a percent of purchases made within a specific period of time. The Company recognizes revenue on sales to distributors that have contractual return rights when the products have been sold by the distributors, unless there is sufficient customer specific sales and sales returns history to support revenue recognition upon shipment. In those instances when revenue is recognized upon shipment to distributors, the Company uses historical rates of return from the distributors to provide for estimated product returns.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company derives revenue primarily from stand-alone sales of its products. In certain cases, the Company&#8217;s products are sold along with services, which include education, training, installation, and/or extended warranty services. As such, some of the Company&#8217;s sales have multiple deliverables. The Company&#8217;s products and services qualify as separate units of accounting and are deemed to be non-contingent deliverables as the Company&#8217;s arrangements typically do not have any significant performance, cancellation, termination and refund type provisions. Products are typically considered delivered upon shipment. Revenue from services is recognized ratably over the period during which the services are to be performed.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For multiple deliverable revenue arrangements, the Company allocates revenue to products and services using the relative selling price method to recognize revenue when the revenue recognition criteria for each deliverable are met. The selling price of a deliverable is based on a hierarchy and if the Company is unable to establish vendor-specific objective evidence of selling price (&#8220;VSOE&#8221;) it uses third-party evidence of selling price (&#8220;TPE&#8221;), and if no such data is available, it uses a best estimated selling price (&#8220;BSP&#8221;). In most instances, particularly as it relates to products, the Company is not able to establish VSOE for all deliverables in an arrangement with multiple elements. This may be due to infrequently selling each element separately, not pricing products within a narrow range, or only having a limited sales history. When VSOE cannot be established, the Company attempts to establish the selling price of each element based on TPE. Generally, the Company&#8217;s marketing strategy differs from that of the Company&#8217;s peers and the Company&#8217;s offerings contain a significant level of customization and differentiation such that the comparable pricing of products with similar functionality cannot be obtained. Furthermore, the Company is unable to reliably determine what similar competitor products&#8217; selling prices are on a stand-alone basis. Therefore, the Company is typically not able to determine TPE for the Company&#8217;s products.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When the Company is unable to establish selling price using VSOE or TPE, the Company uses BSP. The objective of BSP is to determine the price at which the Company would transact a sale if the product or service were sold on a stand-alone basis. The BSP of each deliverable is determined using average discounts from list price from historical sales transactions or cost plus margin approaches based on the factors, including but not limited to, the Company&#8217;s gross margin objectives and pricing practices plus customer and market specific considerations.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has established TPE for its training, education and installation services. TPE is determined based on competitor prices for similar deliverables when sold separately. These service arrangements are typically short term in nature and are largely completed shortly after delivery of the product. Training and education services are based on a daily rate per person and vary according to the type of class offered. Installation services are based on daily rate per person and vary according to the complexity of the products being installed.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Extended warranty services are priced based on the type of product and are sold in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> year durations. Extended warranty services include the right to warranty coverage beyond the standard warranty period. In substantially all of the arrangements with multiple deliverables pertaining to arrangements with these services, the Company has used and intends to continue using VSOE to determine the selling price for the services. The Company determines VSOE based on its normal pricing practices for these specific services when sold separately.</font></div></div>
us-gaap Sales Revenue Net
SalesRevenueNet
58427000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
30835000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
57897000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
30048000 USD
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4825000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9540000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9895000 USD
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5073000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
432000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
312000 USD
CY2013Q2 us-gaap Significant Purchase Commitment Remaining Minimum Amount Committed
SignificantPurchaseCommitmentRemainingMinimumAmountCommitted
6600000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
33458000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
31940000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</font></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31859000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30871000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30985000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32696000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30985000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31170000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31222000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30871000 shares
CY2013Q2 zhne Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
9019000 USD
CY2012Q4 zhne Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
8836000 USD
CY2013Q2 zhne Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
2203000 USD
CY2012Q4 zhne Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
2878000 USD
zhne Provision For Doubtful Accounts Receivable And Sales Returns
ProvisionForDoubtfulAccountsReceivableAndSalesReturns
812000 USD
zhne Provision For Doubtful Accounts Receivable And Sales Returns
ProvisionForDoubtfulAccountsReceivableAndSalesReturns
789000 USD
zhne Standard Product Warranty Time Period
StandardProductWarrantyTimePeriod
P1Y
zhne Termination Notice Period
TerminationNoticePeriod
P30D
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001101680
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31474486 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
ZHONE TECHNOLOGIES INC
dei Trading Symbol
TradingSymbol
ZHNE

Files In Submission

Name View Source Status
0001445305-13-002085-index-headers.html Edgar Link pending
0001445305-13-002085-index.html Edgar Link pending
0001445305-13-002085.txt Edgar Link pending
0001445305-13-002085-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
zhne-20130630.xml Edgar Link completed
zhne-20130630.xsd Edgar Link pending
zhne-20130630_cal.xml Edgar Link unprocessable
zhne-20130630_def.xml Edgar Link unprocessable
zhne-20130630_lab.xml Edgar Link unprocessable
zhne-20130630_pre.xml Edgar Link unprocessable
zhne-6302013x10q.htm Edgar Link pending